Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-28 Purchase |
2024-08-30 4:16 pm |
Inhibrx Biosciences Inc. | INBX | MANHARD KIMBERLY Director |
10,000 | $13.98 | $139,800 | 10,000 (Indirect) |
View |
| 2022-05-03 Sale |
2022-05-04 7:01 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,504 | $4.7564 | $7,154 | 12,376 (Direct) |
View |
| 2021-05-03 Sale |
2021-05-04 6:03 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,529 | $17.66 | $27,009 | 3,163 (Direct) |
View |
| 2020-12-22 Sale |
2020-12-23 4:23 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
10,000 | $20 | $200,000 | 48,416 (Direct) |
View |
| 2020-05-01 Sale |
2020-05-01 6:48 pm |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY Executive VP, Drug Development |
1,158 | $13.97 | $16,176 | 1,158 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-30 Option Award |
2024-05-30 6:11 pm |
N/A 2034-05-30 |
Inhibrx Biosciences Inc. | INXB | MANHARD KIMBERLY Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-05-25 Option Award |
2023-05-30 4:08 pm |
N/A 2033-05-25 |
Inhibrx Inc. | INBX | MANHARD KIMBERLY Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2023-04-13 Exercise |
2023-04-17 5:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 63,766 (Direct) |
View |
| 2023-04-13 Tax Withholding |
2023-04-17 5:26 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,417 | $2.88 | 63,766 (Direct) |
View |
| 2023-01-18 Option Award |
2023-01-20 5:08 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
149,365 | $0 | 149,365 (Direct) |
View |
| 2023-01-13 Tax Withholding |
2023-01-17 5:34 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $3.17 | 66,838 (Direct) |
View |
| 2023-01-13 Exercise |
2023-01-17 5:34 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 66,838 (Direct) |
View |
| 2022-10-31 Other |
2023-01-17 5:34 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,655 | $3.2725 | 66,838 (Direct) |
View |
| 2022-10-13 Tax Withholding |
2022-10-17 4:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $3.76 | 65,540 (Direct) |
View |
| 2022-10-13 Exercise |
2022-10-17 4:36 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 65,540 (Direct) |
View |
| 2022-07-25 Option Award |
2022-07-27 6:21 pm |
N/A 2032-07-25 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
165,961 | $0 | 165,961 (Direct) |
View |
| 2022-07-13 Exercise |
2022-07-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 67,552 (Direct) |
View |
| 2022-07-13 Tax Withholding |
2022-07-15 4:55 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $3.01 | 67,552 (Direct) |
View |
| 2022-05-25 Option Award |
2022-05-26 4:31 pm |
N/A 2032-05-25 |
Inhibrx Inc. | INBX | MANHARD KIMBERLY Director |
15,000 | $0 | 50,759 (Direct) |
View |
| 2022-04-29 Other |
2022-05-04 7:01 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,504 | $3.842 | 12,376 (Direct) |
View |
| 2022-04-13 Exercise |
2022-04-15 5:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 69,564 (Direct) |
View |
| 2022-04-13 Tax Withholding |
2022-04-15 5:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $6.07 | 69,564 (Direct) |
View |
| 2022-01-13 Exercise |
2022-01-14 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
5,814 | $0 | 71,576 (Direct) |
View |
| 2022-01-13 Tax Withholding |
2022-01-14 5:05 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
2,012 | $8.3 | 71,576 (Direct) |
View |
| 2021-10-13 Option Award |
2021-10-15 4:22 pm |
N/A 2031-10-13 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
147,520 | $0 | 165,788 (Direct) |
View |
| 2021-10-13 Exercise |
2021-10-15 4:22 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 165,788 (Direct) |
View |
| 2021-10-13 Tax Withholding |
2021-10-15 4:22 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $10.55 | 165,788 (Direct) |
View |
| 2021-07-13 Tax Withholding |
2021-07-15 4:47 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $13.48 | 18,701 (Direct) |
View |
| 2021-07-13 Exercise |
2021-07-15 4:47 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 18,701 (Direct) |
View |
| 2021-06-07 Option Award |
2021-06-08 5:19 pm |
N/A 2031-06-07 |
Inhibrx Inc. | INBX | MANHARD KIMBERLY Director |
15,000 | $0 | 35,759 (Direct) |
View |
| 2021-04-30 Other |
2021-05-04 6:03 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,529 | $13.9 | 3,163 (Direct) |
View |
| 2021-04-13 Tax Withholding |
2021-04-15 4:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $16.66 | 19,134 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 4:51 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 19,134 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
1,250 | $0 | 19,567 (Direct) |
View |
| 2021-01-13 Tax Withholding |
2021-01-15 4:25 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
433 | $18.16 | 19,567 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-23 4:23 pm |
N/A 2026-12-21 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
10,000 | $0 | 48,416 (Direct) |
View |
| 2020-12-22 Exercise |
2020-12-23 4:23 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
10,000 | $13 | 48,416 (Direct) |
View |
| 2020-10-13 Option Award |
2020-10-15 4:25 pm |
N/A 2030-10-13 |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY EVP, Drug Development |
140,000 | $0 | 140,000 (Direct) |
View |
| 2020-08-21 Option Award |
2020-08-21 4:24 pm |
N/A 2030-08-20 |
Inhibrx Inc. | INBX | MANHARD KIMBERLY Director |
17,259 | $0 | 17,259 (Direct) |
View |
| 2020-04-30 Other |
2020-05-01 6:48 pm |
N/A N/A |
HERON THERAPEUTICS INC. | HRTX | MANHARD KIMBERLY Executive VP, Drug Development |
1,158 | $12.12 | 1,158 (Direct) |
View |